A Clinical Radiomics Nomogram Was Developed by Integrating Radiomics Signatures and Clinical Variables to Distinguish High-Grade ccRCC from Type 2 pRCC

<div>Example of selection the region of interest (ROI) for tumor and reference region. (a), (b), and (c) correspond to the image in the precontrast phase, corticomedullary phase (CMP), and nephrographic phase (NP), respectively. The red circle is for the tumor in three phases. The red oval represents the region in the kidney cortical section used as the reference. These ROIs were consistent for the three scan phases.</div>

Journal of Oncology

fig1

Figure 1

Figure 1: A Clinical Radiomics Nomogram Was Developed by Integrating Radiomics Signatures and Clinical Variables to Distinguish High-Grade ccRCC from Type 2 pRCC 

Figure 1 | A Clinical Radiomics Nomogram Was Developed by Integrating Radiomics Signatures and Clinical Variables to Distinguish High-Grade ccRCC from Type 2 pRCC 